Outcome prediction for patients with renal cell carcinoma

Seminars in Diagnostic Pathology

Volumn 32, Issue 2, 2015, Pages 172-183

  Lohse, Christine M ^a   Gupta, Sounak ^a   Cheville, John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CANCER GRADING; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL PRACTICE; DISTANT METASTASIS; HISTOPATHOLOGY; KIDNEY CARCINOMA; NOMOGRAM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; POSTOPERATIVE PERIOD; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; SARCOMATOID CARCINOMA; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR NECROSIS; TUMOR VOLUME; HUMAN; KIDNEY TUMOR; MORTALITY; PATHOLOGY; PROGNOSIS;

CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 84925268977     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2015.02.008     Document Type: Article

References (70)

1. American Cancer Society Cancer Facts & Figures 2014, American Cancer Society, Atlanta, GA.
2. Eble J.N., Sauter G., Epstein J.I., Sesterhenn I.A. World Health Organization Classification of Tumours. Pathology and genetics of tumors of the urinary system and male genital organs 2004, 12. IARC Press, Lyon, France.
3. Chow W.H., Devesa S.S., Warren J.L., Fraumeni J.F. Rising incidence of renal cell cancer in the United States. J Am Med Assoc 1999, 281(17):1628-1631.
4. Storkel S., Eble J.N., Adlakha K., et al. Classification of renal cell carcinoma: workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997, 80(5):987-989.
5. Kovacs G., Akhtar M., Beckwith B.J., et al. The Heidelberg classification of renal cell tumors. J Pathol 1997, 183(2):131-133.
6. Srigley J.R., Delahunt B., Eble J.N., et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013, 37(10):1469-1489.
7. Cheville J.C., Lohse C.M., Zincke H., Weaver A.L., Blute M.L. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003, 27(5):612-624.
8. Leibovich B.C., Lohse C.M., Crispen P.L., et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol 2010, 183(4):1309-1315.
9. Ljungberg B., Alamdari F.I., Stenling R., Roos G. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 1999, 36(6):565-569.
10. Moch H., Gasser T., Amin M.B., Torhorst J., Sauter G., Mihatsch M.J. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000, 89(3):604-614.
11. Amin M.B., Amin M.B., Tamboli P., et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 2002, 26(3):281-291.
12. Beck S.D., Patel M.I., Snyder M.E., et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 2004, 11(1):71-77.
13. Ficarra V., Martignoni G., Galfano G., et al. Prognostic role of histologic subtypes of renal cell carcinoma after slide revision. Eur Urol 2006, 50(4):786-794.
14. Webster W.S., Thompson R.H., Cheville J.C., et al. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma. Urology 2007, 70(5):900-904.
15. Farrow G.M., Harrison E.G., Utz D.C. Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. Part III. Cancer 1968, 22(3):556-563.
16. Bertoni F., Ferri C., Benati A., Bacchini P., Corrado F. Sarcomatoid carcinoma of the kidney. J Urol 1987, 137(1):25-28.
17. Ro J.Y., Ayala A.G., Sella A., Samuels M.L., Swanson D.A. Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases. Cancer 1987, 59(3):516-526.
18. Akhtar M., Tulbah A., Kardar A.H., Ali M.A. Sarcomatoid renal cell carcinoma: the chromophobe connection. Am J Surg Pathol 1997, 21(10):1188-1195.
19. Cangiano T., Liao J., Naitoh J., Dorey F., Figlin R., Belldegrun A. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol 1999, 17(2):523-528.
20. Delahunt B. Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology 1999, 31(3):185-190.
21. de Peralta-Venturina M., Moch H., Amin M. Sarcomatoid differentiation in renal cell carcinoma. Am J Surg Pathol 2001, 25(3):275-284.
22. Mian B.M., Bhadkamkar N., Slaton J.W., et al. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 2002, 167(1):65-70.
23. Cheville J.C., Lohse C.M., Zincke H., et al. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 2004, 28(4):435-441.
24. Shuch B., Bratslavsky G., Shih J., et al. Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int 2012, 109(11):1600-16006.
25. Zhang B.Y., Thompson R.H., Lohse C.M., et al. Novel prognostic model for patients with sarcomatoid renal cell carcinoma. BJU Int 2015, 115(3):405-411.
26. Gokden N., Nappi O., Swanson P.E., et al. Renal cell carcinoma with rhabdoid features. Am J Surg Pathol 2000, 24(10):1329-1338.
27. Kuroiwa K., Kinoshita U.Y., Shiratsuchi H., et al. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm. Histopathology 2002, 41(6):538-548.
28. Humphrey P.A. Renal cell carcinoma with rhabdoid features. J Urol 2011, 186(2):1432-1437.
29. Chapman-Fredericks J.R., Herrera L., Bracho J., et al. Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma. Ann Diagn Pathol 2011, 15(5):333-337.
30. Przybycin C.G., McKenney J.K., Reynolds J.P., et al. Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma. Am J Surg Pathol 2014, 38(9):1260-1265.
31. Delahunt B., Cheville J.C., Martignoni G., et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 2013, 37(10):1490-1504.
32. Guinan P., Sobin L.H., Algaba F., et al. TNM staging of renal cell carcinoma. Workgroup No. 3. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997, 80(5):992-993.
33. Edge S.B., Byrd D.R., Compton C.C., et al. AJCC Cancer Staging Manual 2010, 479-489. Springer Press, New York, New York. 7th ed.
34. Gospodarowicz M.K., Miller D., Groome P.A., Greene F.L., Logan P.A., Sobin L.H. The process for continuous improvement of the TNM classification. Cancer 2004, 100(1):1-5.
35. Lau W.K., Cheville J.C., Blute M.L., et al. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology 2002, 59(4):532-537.
36. Hafez K.S., Fergany A.F., Novick A.C. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999, 162(6):1930-1933.
37. Zisman A., Pantuck A.J., Dorey F., et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 2001, 19(6):1649-1657.
38. Bonsib S.M., Gibson D., Mhoon M., et al. Renal sinus involvement in renal cell carcinoma. Am J Surg Pathol 2000, 24(3):451-458.
39. Bonsib S.M. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. Am J Surg Pathol 2004, 28(12):1594-1600.
40. Bonsib S.M. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. J Urol 2005, 174(4 Pt 1):1199-1202.
41. Thompson R.H., Leibovich B.C., Cheville J.C., et al. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma. J Urol 2005, 174(4 Pt 1):1218-1221.
42. Thompson R.H., Blute M.L., Krambeck A.E., et al. Patients with pT1 renal cell carcinoma who die from disease after nephrectomy may have unrecognized renal sinus fat invasion. Am J Surg Pathol 2007, 31(7):1089-1093.
43. Trpkov K., Grignon D.J., Bonsib S.M., et al. Handling and staging of renal cell. The International Society of Urological Pathology (ISUP) Consensus Conference recommendations. Am J Surg Pathol 2013, 37(10):1505-1517.
44. Frank I., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade, and necrosis: the SSIGN score. J Urol 2002, 168(6):2395-2400.
45. Frank I., Blute M.L., Cheville J.C., et al. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol 2003, 170(6 Pt 1):2225-2232.
46. Leibovich B.C., Blute M.L., Cheville J.C., et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003, 97(7):1663-1671.
47. Blute M.L., Leibovich B.C., Cheville J.C., Lohse C.M., Zincke H. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 2004, 172(2):465-469.
48. Crispen P.L., Breau R., Allmer C., et al. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol 2011, 59(1):18-23.
49. Dimashkieh H.H., Zang X., Lohse C.M., et al. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol 2006, 176(5):1978-1982.
50. Kavolius J.P., Mastorakos D.P., Pavlovivh C., Russo P., Burt M.E., Brady M.S. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998, 16(6):2261-2266.
51. van der Poel H.G., Roukema J.A., Horenblas S., ven Geel A.N., Debruyne F.M. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 1999, 35(3):197-203.
52. Alt A.L., Boorjian S.A., Lohse C.M., et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 2011, 117(13):2873-2882.
53. Frank I., Blute M.L., Cheville J.C., et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003, 170(6):2217-2220.
54. Hand J.R., Broders A.C. Carcinoma of the kidney: the degree of malignancy in relation to factors bearing on prognosis. J Urol 1932, 28(4):199-216.
55. Skinner D.G., Colvin R.B., Vermillion C.D., Pfister R.C., Leadbetter W.F. Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases. Cancer 1971, 28(5):1165-1177.
56. Fuhrman S.A., Lasky L.C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6(7):655-663.
57. Delahunt B. Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol 2009, 22(Supp 2):S24-S36.
58. Delahunt B., Sika-Paotonu D., Bethwaite P.B., et al. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 2007, 31(6):957-960.
59. Lam J.S., Shvarts O., Said J.W., et al. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer 2005, 103(12):2517-2525.
60. Zubac D.P., Bostad L., Gestblom C., et al. Renal cell carcinoma: a clinicopathologic follow-up study after radical nephrectomy. Scand J Urol and Nephrol 2007, 41(3):191-197.
61. Katz M.D., Serrano M.F., Grubb R.L., et al. Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol 2010, 183(3):909-914.
62. Pichler M., Hutterer G.C., Chromecki T.F., et al. Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol 2012, 137(2):283-289.
63. Brinker D.A., Amin M.B., de Peralta-Venturina M., et al. Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers. Am J Surg Pathol 2000, 24(7):988-995.
64. Foria V., Surendra T., Poller D.N. Prognostic relevance of extensive necrosis in renal cell carcinoma. J Clin Pathol 2005, 58(1):39-43.
65. Delahunt B., McKenney J., Lohse C.M., et al. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol 2013, 37(3):311-312.
66. Klatte T., Said J.W., de Martino M., et al. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma. Higher prognostic accuracy of extent based rather than presence/absence classification. J Urol 2009, 181(4):1558-1564.
67. Kattan M.W., Reuter V., Motzer R.J., Katz J., Russo P. A postoperative nomogram for renal cell carcinoma. J Urol 2001, 166(1):63-67.
68. Sorbellini M., Kattan M.W., Snyder M.E., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005, 173(1):48-51.
69. Zisman A., Pantuck A.J., Wieder J., et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002, 20(23):4559-4566.
70. Sukov W.R., Lohse C.M., Leibovich B.C., et al. Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. J Urol 2012, 187(1):54-59.